Esteatose hepática não alcoólica: relação com a síndrome metabólica e os fatores de risco cardiovascular em adolescentes obesos

Wener Barbosa Resende; Carlos Eduardo Caetano; Anamaria Caixeta Nogueira; Sandra Xavier; Rafael Dias Costa e Silva; João Elias Nunes; Heitor Dos Santos; Nadia Carla Cheik

doi:10.5020/2421

Autores/as

Wener Barbosa Resende
Carlos Eduardo Caetano
Anamaria Caixeta Nogueira
Sandra Xavier
Rafael Dias Costa e Silva
João Elias Nunes
Heitor Dos Santos
Nadia Carla Cheik

DOI:

https://doi.org/10.5020/2421

Palabras clave:

Adolescente, Obesidad Pediátrica, Hígado Gras, , Síndrome X Metabólico, Enfermedades Cardiovasculares

Resumen

Objetivo: Evaluar la asociación entre la esteatosis hepática no alcohólica (EHNA), síndrome metabólico (SM) y factores de riesgo cardiovascular (FRCs) en adolescentes obesos. Métodos: Estudio observacional del tipo trasversal com abordaje cuantitativo realizado entre junio y agosto de 2011. Los voluntarios fueron seleccionados al azar y encaminados para evaluación clínica en el sector de endocrinología y cardiología del hospital de la Universidad Federal de Uberlandia. Participaron 34 adolescentes entre 14 y 19 años que estaban por encima Del percentil 95 de la curva de crecimiento. La EHNA fue analizada con la ultrasonografía. La SM y los FRCs fueron identificados a través de criterios de la International Diabetes Federtion. Resultados: La muestra fue constituida de 14 individuos del sexo masculino y 20 del sexo femenino con media de edad de 16,8±1,6años y media del índice de masa corporal (IMC) de 35,7±3,9. La ocurrencia de EHNA y SM fue del 76,5% (n=26) y 50% (n=17), respectivamente. El sexo masculino presentó mayor ocurrencia de EHNA (78,6%, n=11), SM (64,3%, n=09) y asociación de EHNA y SM (50%, n=07). Respecto a los FRCs, el 100% (n=34), 61,8% (n=21) y el 52,9% (n=18) de los adolescentes presentaron valores mayores de la circunferencia de cintura (CC), de la low-densitylipoprotein cholesterol (LDL-C) y tensión arterial sistólica (TAS), respectivamente, y el 52,9% (n=18) presentó bajos niveles de high-density lipoprotein cholesterol (HDL-C). Hubieron correlaciones entre SM y triglicérides, TAS y diastólica y HDL-C, y entre EHNA, IMC y CC. Conclusión: Se observó una elevada ocurrencia de EHNA, SM y FRCs en adolescentes obesos. Uma fuerte correlación fue observada entre EHNA y SM, y entre FRCs y EHNA y SM doi:10.5020/18061230.2014.p131

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatoloty. 2012;55(6):2005-23.

Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis. Ann. Rev Pathol Mech Dis. 2010;5:145-171.

Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease. Circulation. 2008;118(3):277-83.

Perazzo H, Poynard T, Dufour JF. The Interactions of Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases. Clin Liver Dis. 2014;18(1):233-48.

Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a followup study for up to 20 years. Gut. 2009;58(11):1538-44.

Erickson SK. Nonalcoholic fatty liver disease. J Lipid Res. 2009;50(Suppl):S412-S416.

Ferolla SM, Ferrari TC, Lima ML, Reis TO, Tavares-Jr WC, Couto OF, et al. Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a crosssectional study. Clinics (Sao Paulo). 2013;68(1):11-17.

Cotrim HP, Parise ER, Oliveira CP, Leite N, Martinelli A, Galizzi J, et al. Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile. Ann Hepatol. 2011;10(1):33-7.

Souza FIS, Amâncio OMS, Sarni ROS, Pitta TS, Fernandes AP, Fonseca FLA, et al. Doença hepática gordurosa não alcoólica em escolares obesos. Rev Paul Pediatr. 2008;26(2):136-41.

Soler GLN, Silva AWSM, Silva VCG, Teixeira RJ. Doença hepática gordurosa não-alcoólica:associação com síndrome metabólica e fatores de risco cardiovascular. Rev. SOCERJ. 2008;21(2):94-100.

Caranti DA, Lazzer S, Dâmaso AR, Agosti F, Zennaro R, de Mello MT, et al. Prevalence and risk factors of metabolic syndrome in Brazilian and Italian obese adolescents: a comparison study. Int J Clin Pract.2008;62(10):1526-32.

Angurana SK, Angurana RS. Prevalence of metabolic syndrome in adolescents: Reason to worry. Indian J Endocrinol Metab. 2013;17(6):1135-6.

Moraes ACF, Fulaz CS, Oliveira Netto ER, Reichert FF.Prevalência de síndrome metabólica em adolescentes:uma revisão sistemática. Cad Saúde Pública.2009;25(6):1195-202.

Campos L de A, Amancio OMS, Costa e Forti A.Impact of obesity on metabolic syndrome in Brazilian adolescents - a population-based study. Diabetes Care.2013;36(9):e139-40.

Stanley TL, Chen ML, Goodman E. The typology ofmetabolic syndrome in the transition to adulthood. J Clin Endocrinol Metab. 2014;99(3):1-9.

Instituto Brasileiro de Geografia e Estatística – IBGE.Pesquisa de Orçamentos Familiares - POF 2008-2009.Comunicação Social 27 de agosto de 2010 [acesso em 2014 Jan 4]. Disponível em: http://saladeimprensa.ibge.gov.br/index.phpoption=com_saladeimprensa&view=noticias&id=1&paginar=1&quantidade=10&pa gina=1&busca=1&Itemid=1719&data-inicio=&data-fim=&alvo=obesidade+na+adolescencia.

Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, et al. 2000 Centers for Disease Control (CDC) growth charts for the United States: methods and development. Vital Health Stat. 2002;11(246):1-190.

Marshall WA, Tanner JM. Variations in pattern of puberal changes in girls. Arch Dis Childh.1969;44(233):291-303.19. Marshall WA, Tanner JM. Variations in pattern of puberal changes in boys. Arch Dis Childh.1970;45(239):13-23.

Moll AJ. Esteatose hepática: avaliação por ultrasonografia. Informativo Med D’Or (RJ). 2006;6:6-7.

Saadeh S, Younossi ZM, Reme EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterol.2002;123(3):745-50.

Diniz ALD, Tomé RAF, Debs CL, Carraro R, Roever LB, Pinto RMC. Avaliação da reprodutibilidade ultrassonográfica como método para medida da gordura abdominal e visceral. Radiol Bras. 2009;42(6):353–7.

Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents: the IDF consensus. Diabetes Voice.2007;52(4):29-32.

Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The Methabolic Syndrome: A Global Public Health Problem and A New Definition. J Athrosclerosis Thrombosis. 2005;15(6):295-300.

V Diretrizes Brasileiras de Dislipidemias e Prevenção da Aterosclerose. Arq Bras Cardiol. 2013;101(4Supl.1):1-22.

International Diabetes Federation – IDF. The IDF consensus worldwide definition of the metabolic syndrome [acesso em 2014 Jan 10]. April 14, 2005. Disponível em: http://www.idf.org/metabolicsyndrome

Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome: a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine. 2006;23(5):469–80.

Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica - ABESO. Diretrizes brasileiras de obesidade 2009/2010 [acesso em 2014 Jan 20]. Disponível em: http://www.abeso.org.br/pdf/diretrizes_brasileiras_obesidade_2009_2010_1.pdf.

Van Grouw J, Volpe SL. Childhood obesity in America.Current Opinion in Endocrinology, Diabetes & Obesity.2013;20(5):396-400.

Travi MIC, Bastos PRHO, Pontes ERJC. Prevalência de sobrepeso, obesidade e circunferência abdominal alterada em escolares de 6 a 11 anos de idade em Campo Grande/MS. Rev Bras Promoç Saúde. 2011;24(1):54-62.

Balakrishnan PL. Identification of Obesity and Cardiovascular Risk Factors in Childhood and Adolescence. Pediatr Clin North Am. 2014;61(1):153-71.

Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med. 2010;362(6):485-93.

Corey KE, Kaplan LM. Obesity and liver disease: the epidemic of the twenty-first century. Clin Liver Dis.2014;18(1):1-18.

Ramos MLM, Pontes ERJC, Ramos MLM, Barros VRSP. Sobrepeso e obesidade em escolares de 10 a 14 anos. Rev Bras Promoç Saúde. 2013;26(2):223-32.

Yilmaz Y, Younossi ZM. Obesity-Associated Nonalcoholic Fatty Liver Disease. Clin Liver Dis.2014;18(1):19-31.

Rizzo AC, Goldberg TB, Silva CC, Kurokawa CS, Nunes HR, Corrente JE. Metabolic syndrome risk factors in overweight, obese, and extremely obese Brazilian adolescents. Nutr J. 2013;12(19):1-9.

Barzin M, Asghari G, Hosseinpanah F, Mirmiran P, Azizi F. The association of anthropometric indices in adolescence with the occurrence of the metabolic syndrome in early adulthood. Pediatr Obes. 2013;8(3):170-7.

Fu JF, Shi HB, Liu LR, Jiang P, Wang CL, Liu XY. Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children? World J Gastroenterol. 2011;17(6):735-42.

Fernandes MTB, Ferraro AA, Azevedo RA, Fagundes Neto U. Metabolic differences between male and female adolescents with non-alcoholic fatty liver disease, as detected by ultrasound. Acta Paediatrica.2010;99(8):1218-23.

Ford ES, Li C, Zhao G. Prevalence of the Metabolic Syndrome Among U.S. Adolescents Using the Definition From the International Diabetes Federation. Diabetes Care. 2008;31(3):587-9.